Interventional EUS for the diagnosis and treatment of locally advanced pancreatic cancer.
Endoscopic ultrasound (EUS) evolved as the diagnostic test of choice evaluating suspected pancreatic tumors. Coupled with fine needle aspiration (FNA), EUS provides high accuracy for the diagnosis and staging of pancreatic cancer. Novel EUS based techniques have emerged as a safe minimally invasive alternative to the surgical or radiological approaches. By allowing better pain control, delivering antitumor therapies or draining obstructed bile ducts, such techniques hold a big promise to improve the quality of life of patients with unresectable pancreatic cancer. In this review, we will discuss the role EUS-FNA plays in the diagnosis, staging and treatment of patients with locally advanced pancreatic cancer.
Al-Haddad
Mohammad
M
Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
Eloubeidi
Mohamad A
MA
D000970:Antineoplastic Agents / Q000008:administration & dosage; D044963:Biopsy, Fine-Needle / Q000379:methods; D001918:Brachytherapy / Q000379:methods; D002277:Carcinoma / Q000000981:diagnostic imaging* / Q000473:pathology / Q000628:therapy*; D003938:Diagnostic Techniques, Digestive System; D018450:Disease Progression; D004322:Drainage / Q000379:methods; D019160:Endosonography / Q000379:methods; D006801:Humans; D015552:Injections, Intralesional; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology / Q000628:therapy*; D018084:Ultrasonography, Interventional / Q000379:methods*
D000970:Antineoplastic Agents